Sometimes students start the seeds of rebellion that force governments to change stupid policies, graft, wars, and central planning.
If enough students begin to expose government corruption for what it is, perhaps adults will be too ashamed to attempt to make them bear all of the burdens created by parents and grandparents of today’s generations.
Read on to see what these young journalists discovered about how the FDA works…
Please Note this headline is using the word “Biased” Not “Based” I misread it several times. Thought I’d warn you.
How Fascism Creates Science-Biased Medicine in Federal Policies
By Dr. Mercola
As stated in their mission statement, the US Food and Drug Administration (FDA) is responsible for protecting public health by assuring the safety and efficacy of drugs, biological products, medical devices, food, and more.1
It’s a tall order, no doubt, but the FDA makes many glaring omissions or, some might say, blatant oversights that put the public’s health at risk. Yet, the public is quite understanding and tolerant of the FDA’s mistakes and industry-friendly positions.
For instance, even as they continue to ignore the risks of antibiotics in animal feed, deceive you about mercury amalgams, and allow Americans to consume questionable foods that are banned in other countries…
There is no major public uproar or demand for a (much-needed) overall of the agency. But it is hard to defend an agency that continually acts against the best interests of the public they’re entrusted to defend.
Now, due to the efforts of a professor and his students at the Arthur L. Carter Institute of Journalism at New York University, we have yet another example of the FDA failing to warn Americans, in this case about grave concerns due to falsifications in published data.
FDA Uncovers Fraud, Incompetence, and Misconduct in Clinical Trials… Says Nothing
The FDA reviews several hundred clinical trial locations that conduct research on human participants each year in order to be sure they’re engaging in good clinical practice. But what happens when they find evidence of questionable procedures or practices?
In the most serious of cases, the FDA can classify it as “official action indicated,” or OAI. This is reserved for “severe” forms of clinical trial violations, including “objectionable conditions or practices” that warrant compulsory regulatory action, as opposed to “voluntary action indicated” for lesser violations.”2
Now, if a trial had been deemed OAI by the FDA, you might assume that you’d see evidence of that when reading the results of studies based on said data. But that would be a liberal assumption. Researchers conducted a review of FDA inspection reports between 1998 and 2013.
They found 60 clinical trials that had been classified as OAI, and these trials had been used for data in 78 published articles. Out of those 78 studies, onlythree included mentions of the violations found by the FDA!
And we’re not talking about small, innocent mistakes. The violations included fraud, incompetence, and misconduct. This means that anyone browsing a medical journal might be making decisions based on fraudulent published studies.
Studies that the FDA knows contain grave errors… but chose not to say anything about. While you might not personally read this misleading data, your doctor might. As the study’s lead researcher, Charles Seife, noted:3
“Your physician makes decisions based upon what he knows from the peer-reviewed literature… If that literature is tainted in some way without the physician knowing, then the physician is making treatment decisions based upon bad data.”
Widespread Scientific Fraud, Limb Amputations… Even a Related Homicide Case!
In all, the study found about 2 percent of the close to 650 FDA inspections were classified as OAI. Among the violations was a trial in which patients were treated with stem cells to treat poor blood flow in a leg.
The trial reported that all patients reported improvement in their limbs… but one person had to have a foot amputated two weeks after the treatment.
In another case, the FDA said “systematic and widespread scientific fraud” made a trial of the blood-thinning drug rivaroxaban unreliable. But no mention of this fraud is made in the journals that published its findings.4
In another particularly egregious case, a researcher falsified documents that lead to the death of a chemotherapy patient. The researcher pleaded guilty to fraud and went to prison for criminally negligent homicide … but again, the related published studies make no mention of this.5 Of the 57 OAI trials:6
- 22 had falsified information
- 14 trials had researchers who failed to report adverse events
- 42 trials had violations of the trial’s protocols
- 35 trials had record-keeping errors
- 30 trials had researchers who failed to protect patient safety or acquire informed consent
FDA Says They’re Moving Toward Transparency, Yet Heavily Redacts Information